Stay updated on KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial

Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-27T12:10:56.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about a Phase 3 clinical study for KarXT related to psychosis associated with Alzheimer's Disease, while a new identifier for the study has been added.
    Difference
    17%
    Check dated 2025-04-20T06:21:48.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect that the study is now active and not recruiting, with a total of 119 locations instead of the previous 154. Additionally, several local institutions and their contact details have been removed, indicating a significant reduction in available sites for the study.
    Difference
    59%
    Check dated 2025-04-05T16:53:02.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page has updated contact information for several locations and research centers, including changes in phone numbers and addresses, as well as the removal of outdated dates and recruitment statuses.
    Difference
    2%
    Check dated 2025-03-08T01:43:11.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The webpage has updated key contact information and locations for clinical research sites, including new phone numbers and addresses, while removing outdated details. Notably, the site names have changed from 'Vertex Research Group' to 'Vertex Clinical Research, LLC' and the status of recruitment has been updated.
    Difference
    4%
    Check dated 2025-02-21T11:18:32.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    0.7%
    Check dated 2025-02-13T08:15:19.000Z thumbnail image

Stay in the know with updates to KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.